Andrew Huberman

Andrew Huberman is an associate professor of neurobiology and ophthalmology at Stanford University School of Medicine, where he moved his lab in 2016 after five years at UC San Diego [1]. In 2021 he launched the Huberman Lab podcast, which by 2023 had become the third most popular podcast globally on Spotify according to reporting cited in a March 2024 New York Magazine profile [1][3][4].

On an Ask Me Anything episode of his own podcast, Huberman said he takes 500 mg of nicotinamide riboside (NR) and 1 to 2 grams of nicotinamide mononucleotide (NMN) daily, taken sublingually within one to two hours of waking, stating his goal is "a lot more sustained mental and physical energy throughout the day" rather than lifespan extension specifically [2]. On resveratrol, he told listeners there is "very little, if any, direct evidence that resveratrol can increase lifespan," while still taking 400 to 800 mg per day of grapeseed extract for its vascular effects [2]. He has also described undergoing NAD+ intravenous infusions twice, calling the experience "pretty darn uncomfortable" and noting he knows of no clinical trial testing NAD+ infusions for the vigor benefits he sought [2].

Huberman's sponsorship arrangement with AG1, the greens-powder supplement brand formerly called Athletic Greens, has drawn public scrutiny over its scale and disclosure. A widely circulated 2024 estimate discussed on the r/HubermanLab subreddit put AG1's payments to Huberman at approximately $2 million per year, a figure repeated across podcast-industry commentary tracking his sponsor list, though Huberman has not published his own sponsorship contracts publicly for independent verification [5]. AG1's own product marketing partner page for Huberman confirms an active, ongoing commercial partnership between the two [6]. A 2024 analysis from McGill University's Office for Science and Society specifically criticized AG1 and a related product, AGZ, for making health claims that outpace the underlying evidence, in the context of Huberman's promotional role [7].

In March 2024 the Guardian reported on a New York Magazine investigation, published the same month, that examined Huberman's personal conduct and public scientific communication together, describing him as a "wellness bro" whose credentials as a tenured Stanford professor lend outsized authority to health claims that sometimes outpace the cited research [3][4]. The New York Magazine piece itself, titled "Andrew Huberman's Mechanisms of Control," focused on reported inconsistencies between his public persona and private conduct, rather than a technical rebuttal of specific supplement claims [4]. Huberman has not disputed the factual core of his supplement regimen or sponsorship relationships in public statements responding to the coverage; his response focused on the personal-conduct allegations.

On balance, Huberman's public statements about longevity supplements are frequently more hedged than the marketing language of brands he is paid to promote. He has told his audience directly that resveratrol's lifespan evidence in humans is weak and that no clinical trial supports NAD+ infusions for vigor, framing his own use as personal experimentation rather than an evidence-backed protocol [2]. He has also said, on his own show, that supplementation should not be the foundation of health and that light exposure, sleep, movement, and stress modulation come first [2].

The plain takeaway: Huberman discloses his supplement use and hedges the evidence more carefully than most paid wellness influencers, but he is simultaneously paid millions of dollars annually by a supplement company whose product claims have been independently criticized as overstated, and listeners cannot easily separate his personal clinical judgment from his commercial incentive without outside reporting.